|
||||||||
 |
 |
"...consumers must become much more involved in their health and health care. Unless patients comply with care and take responsibility for their health, even the best doctor or team will fail."
Michael E. Porter, Ph.D. writing in New England Journal of Medicine (July 9, 2009)
"We have limited health care resources... They are wasted if people don't follow through on treatment."
Robin DiMatte, University if California professor disussing a new study on physician communication and patient adherence to treatment |
 |
Pharmaceutical Companies
America’s pharmaceutical companies develop and market a vast array of prescriptions drugs, which patients spend hundreds of billions each year to buy. These drugs have the potential to save lives and forestall future illnesses. Yet, studies have indicated that many people either take the wrong dosages or fail to take their medications at all, further burdening the health care system in terms of increased utilization and cost. For example, a New England Healthcare Institute report in August 2009 found that those who don't take medications as prescribed cost the health system up to $290 billion per year in increased medical costs.
Pharmaceutical companies know these statistics well; what has been harder to determine is where the connection between prescription creation and patient compliance breaks down. Are patients confused about their medicines? Do doctors fail to communicate the regimen appropriately? The speculation has continued for decades, but few hard, actionable facts have surfaced.
CarePartners Plus has an answer. We have created a breakthrough technology that helps pharmaceutical companies better understand how their products are prescribed, the context provided by doctors, and how patients follow through – or fail to – after the doctor’s office visit. Our patient-interactive program gives you timely evidence and useful knowledge to advance your understanding of how your products are actually used – through data shared by patients themselves and delivered to you by an unbiased third party.
Our technology is called Wellby™. This web-based program gathers patient and provider data by surveying patients at the end of doctor’s office visit. Wellby gathers information regarding patient perceptions of their visits and their health goals, including information on the prescriptions they received and their understanding of how to take them safely. Wellby then makes this data available to you in near-real-time through customizable reports.
Wellby has been tested in the real world. In a study in Pennsylvania, patients were found to be willing to participate in the Wellby survey at substantially greater rates (at least 10 times greater) than those reported for mail-home surveys. And, on average, participants completed approximately 97% of the survey, indicating its ease of use. The means that you are more likely to receive information from a broad range of patients, covering multiple products and intended therapies.
The CarePartners Plus team knows the challenges you face. Our diverse backgrounds in hospitals, clinics, administration, government and other realms make us excellent partners who understand your goals and challenges. We look forward to helping you achieve your objectives with our revolutionary technology and program.
Find out more about how CarePartners Plus can help you better understand how your pharmaceutical products are being prescribed and used in the marketplace.